| Reporting Organization: | Nutrition International |
|---|---|
| Total Budget ($CAD): | $ 75,000,000 |
| Timeframe: | March 21, 2011 - December 31, 2015 |
| Status: | Completion |
| Contact Information: | Unspecified |
| Sub-Saharan Africa - $ 59,497,500.00 (79.33%) | |
|
|
|
| North Africa - $ 8,002,500.00 (10.67%) | |
|
|
|
| Southeast Asia - $ 2,497,500.00 (3.33%) | |
|
|
|
| South Asia - $ 2,047,500.00 (2.73%) | |
|
|
|
| East Asia - $ 1,822,500.00 (2.43%) | |
|
|
|
| Central Asia - $ 1,140,000.00 (1.52%) | |
|
|
|
| Nutrition (80 %) | |
|
|
|
| Health Systems, Training & Infrastructure (10 %) | |
|
|
|
| Primary Health Care (10 %) | |
|
|
|
This project aims to promote the integration of micronutrients into existing country systems along the continuum of care. It is designed to work in partnership with others to address maternal, newborn and child health through providing essential health and nutrition services. Working through existing health systems to identify optimal delivery mechanisms, the Micronutrient Initiative (MI) aims to provide support to strengthen those systems that need it most. The objective is to deliver therapeutic zinc in conjunction with oral rehydration therapy to reduce child mortality and illness due to diarrhea; to deliver vitamin A supplements to reduce child mortality; to increase production of ready-to-use therapeutic foods to treat cases of severe acute malnutrition; and to deliver iron and folic acid to avoid anaemia at term among pregnant women. Working with other partners, MI also aims to implement initiatives to improve antenatal care, care at birth, and postpartum and newborn care.
| Gender and age: | Adult women Under-5 children Newborns |
|---|---|
| Total Direct Population: | 36,500,000 |
Unspecified
Return to topUnspecified
Results achieved as of March 2012 include: 32 530 children with diarrhoea treated with zinc and oral rehydration salts;1 million children provided with two doses of vitamin A through routine contacts in Kenya; and sufficient vitamin A supplements procured and shipped for 7 million children to get their two annual doses in 2012 through routine health contacts in four countries.
